Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 637512, 8 pages
http://dx.doi.org/10.1155/2012/637512
Research Article

Oleifolioside A, a New Active Compound, Attenuates LPS-Stimulated iNOS and COX-2 Expression through the Downregulation of NF-κB and MAPK Activities in RAW 264.7 Macrophages

College of Natural Resources and Life Science, BK21 Center for Silver-Bio Industrialization, Dong-A University, Busan 604-714, Republic of Korea

Received 15 April 2012; Revised 30 May 2012; Accepted 30 May 2012

Academic Editor: Jae Youl Cho

Copyright © 2012 Hai Yang Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. H. Bae, The Medicinal Plants of Korea, Kyo-Hak Publishing, Seoul, Korea, 2000.
  2. B. Y. Park, B. S. Min, S. R. Oh et al., “Isolation and anticomplement activity of compounds from Dendropanax morbifera,” Journal of Ethnopharmacology, vol. 90, no. 2-3, pp. 403–408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. I. M. Chung, H. K. Song, S. J. Kim, and H. I. Moon, “Anticomplement activity of polyacetylenes from leaves of Dendropanax morbifera Leveille,” Phytotherapy Research, vol. 25, no. 5, pp. 784–786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. I. M. Chung, M. Y. Kim, W. H. Park, and H. I. Moon, “Antiatherogenic activity of Dendropanax morbifera essential oil in rats,” Pharmazie, vol. 64, no. 8, pp. 547–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. I. M. Chung, M. Y. Kim, S. D. Park, W. H. Park, and H. I. Moon, “In vitro evaluation of the antiplasmodial activity of Dendropanax morbifera against chloroquine-sensitive strains of Plasmodium falciparum,” Phytotherapy Research, vol. 23, no. 11, pp. 1634–1637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. I. Moon, “Antidiabetic effects of dendropanoxide from leaves of Dendropanax morbifera Leveille in normal and streptozotocin-induced diabetic rats,” Human and Experimental Toxicology, vol. 30, no. 8, pp. 870–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Özipek, A. A. Dönmez, I. Çaliş, R. Brun, P. Rüedi, and D. Tasdemir, “Leishmanicidal cycloartane-type triterpene glycosides from Astragalus oleifolius,” Phytochemistry, vol. 66, no. 10, pp. 1168–1173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. T. Rietschel, T. Kirikae, F. U. Schade et al., “Bacterial endotoxin: molecular relationships of structure to activity and function,” FASEB Journal, vol. 8, no. 2, pp. 217–225, 1994. View at Google Scholar · View at Scopus
  9. S. Gallucci, C. Provenzano, P. Mazzarelli, F. Scuderi, and E. Bartoccioni, “Myoblasts produce IL-6 in response to inflammatory stimuli,” International Immunology, vol. 10, no. 3, pp. 267–273, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Nakagawa, Y. Arai, T. Kishida et al., “Lansoprazole inhibits nitric oxide and prostaglandin E2 production in murine macrophage RAW 264.7 cells,” Inflammation, vol. 35, no. 3, pp. 1062–1068, 2012. View at Google Scholar
  11. J. MacMicking, Q. W. Xie, and C. Nathan, “Nitric oxide and macrophage function,” Annual Review of Immunology, vol. 15, pp. 323–350, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Isomäki and J. Punnonen, “Pro- and anti-inflammatory cytokines in rheumatoid arthritis,” Annals of Medicine, vol. 29, no. 6, pp. 499–507, 1997. View at Google Scholar · View at Scopus
  13. P. J. Shaw, M. F. McDermott, and T. D. Kanneganti, “Inflammasomes and autoimmunity,” Trends in Molecular Medicine, vol. 17, no. 2, pp. 57–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Alirezaei, C. C. Kemball, and J. L. Whitton, “Autophagy, inflammation and neurodegenerative disease,” European Journal of Neuroscience, vol. 33, no. 2, pp. 197–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. I. Arias, M. A. Aller, F. Sánchez-Patan, and J. Arias, “Inflammation and cancer: is trophism the link?” Surgical Oncology, vol. 15, no. 4, pp. 235–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W. K. Jung, D. Y. Lee, C. Park et al., “Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases,” British Journal of Pharmacology, vol. 159, no. 6, pp. 1274–1285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. O. Moon, S. Y. Park, K. J. Lee et al., “Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia,” International Immunopharmacology, vol. 7, no. 8, pp. 1092–1101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Kang, K. Lee, and V. Castranova, “Nitric oxide up-regulates DNA-binding activity of nuclear factor-κB in macrophages stimulated with silica and inflammatory stimulants,” Molecular and Cellular Biochemistry, vol. 215, no. 1-2, pp. 1–9, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Honda, “Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE2 production in chondrocytes,” Journal of Oral Science, vol. 53, no. 1, pp. 87–96, 2011. View at Publisher · View at Google Scholar
  20. P. A. Baeuerle and D. Baltimore, “Nf-κB: ten years after,” Cell, vol. 87, no. 1, pp. 13–20, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Coulter, H. O. McCarthy, J. Xiang et al., “Nitric oxide-A novel therapeutic for cancer,” Nitric Oxide, vol. 19, no. 2, pp. 192–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. V. L. Dawson and T. M. Dawson, “Nitric oxide in neurodegeneration,” Progress in Brain Research, vol. 118, pp. 215–229, 1998. View at Google Scholar · View at Scopus
  23. A. G. Stewart, L. H. Phan, and G. Grigoriadis, “Physiological and pathophysiological roles of nitric oxide,” Microsurgery, vol. 15, no. 10, pp. 693–702, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Zamora, Y. Vodovotz, and T. R. Billiar, “Inducible nitric oxide synthase and inflammatory diseases,” Molecular Medicine, vol. 6, no. 5, pp. 347–373, 2000. View at Google Scholar · View at Scopus
  25. J. K. Kundu, Y. K. Shin, and Y. J. Surh, “Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets,” Biochemical Pharmacology, vol. 72, no. 11, pp. 1506–1515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Google Scholar · View at Scopus
  27. M. Karin, “The beginning of the end: IκB kinase (IKK) and NF-κB activation,” Journal of Biological Chemistry, vol. 274, no. 39, pp. 27339–27342, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. D. W. Gilroy, T. Lawrence, M. Perretti, and A. G. Rossi, “Inflammatory resolution: new opportunities for drug discovery,” Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 401–416, 2004. View at Google Scholar · View at Scopus
  29. J. H. Kim, Y. M. Park, J. S. Shin et al., “Fraxinellone inhibits lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 expression by negatively regulating nuclear factor-kappa B in RAW 264.7 macrophages cells,” Biological and Pharmaceutical Bulletin, vol. 32, no. 6, pp. 1062–1068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Kim, M. S. Lee, T. S. Shin et al., “Phlorofucofuroeckol A inhibits the LPS-stimulated iNOS and COX-2 expressions in macrophages via inhibition of NF-κB, Akt, and p38 MAPK,” Toxicology in Vitro, vol. 25, no. 8, pp. 1789–1795, 2011. View at Google Scholar